Pazopanib HCl is a novel multi-target inhibitor of VEGFR1, VEGFR2, VEGFR3, PDGFR, FGFR, c-Kit and c-Fms.
This report contains market size and forecasts of Pazopanib HCl API in global, including the following market information:
Global Pazopanib HCl API Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Pazopanib HCl API Market Sales, 2017-2022, 2023-2028, (MT)
Global top five Pazopanib HCl API companies in 2021 (%)
The global Pazopanib HCl API market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Min Purity Less Than 98% Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Pazopanib HCl API include Tecoland, FCDA, BIOBERRY, Abcr, Dr. Reddy’s Laboratories, Pharmaffiliates, Jigs chemical, MuseChem and Hairuichem, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Pazopanib HCl API manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Pazopanib HCl API Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Pazopanib HCl API Market Segment Percentages, by Type, 2021 (%)
Min Purity Less Than 98%
Min Purity 98%-99%
Min Purity More Than 99%
Global Pazopanib HCl API Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Pazopanib HCl API Market Segment Percentages, by Application, 2021 (%)
Research
Pharmaceutical
Global Pazopanib HCl API Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Pazopanib HCl API Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Pazopanib HCl API revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Pazopanib HCl API revenues share in global market, 2021 (%)
Key companies Pazopanib HCl API sales in global market, 2017-2022 (Estimated), (MT)
Key companies Pazopanib HCl API sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Tecoland
FCDA
BIOBERRY
Abcr
Dr. Reddy’s Laboratories
Pharmaffiliates
Jigs chemical
MuseChem
Hairuichem
Wuhan Fortuna Chemical
Shijiazhuang Dingmin Pharmaceutical Sciences
AlchemyPharm